Aims and Scope
Lung Cancer is a peer-reviewed medical journal published by Elsevier originally published on behalf of the International Association for the Study of Lung Cancer (until 2006). As of 2015, it is published on behalf of the International Lung Cancer Consortium, the European Thoracic Oncology Platform, and the British Thoracic Oncology Group. It includes original research and review articles of relevance to lung cancer.
Key Metrics
9.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
141
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.87
5-Year SI
5-year SI
- N/A 2-year SI
- 0.84 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Oncology
SJR
- Q1 Oncology
- Q1 Cancer Research
- Q1 Pulmonary and Respiratory Medicine
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.44
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Cancer
- Lung cancer
- Lymph node
- Progression-free survival
- Computed tomography
- Crizotinib
- Immunotherapy
- Exon
- Immune checkpoint inhibitors
- Epidermal growth factor receptor
- Chemoradiotherapy
- Overall survival
- Lung
- Adenocarcinoma
- Toxicity
- Artificial intelligence
- Cohort study
- Central nervous system
- Met amplification
- Mesothelioma
Journal Specifications
| Overview | |
| Publisher | ELSEVIER IRELAND LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1985 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Lung Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
WITHDRAWN: Cost-effectiveness of video-assisted thoracoscopic surgery compared to open lobectomy in patients with early-stage lung cancer: Findings from the VIOLET randomised controlled trial
- 1 Dec 22
- Lung Cancer
-
Full paper
WITHDRAWN: Patterns of care for patients with non-operable T1-4 N+ M0 non-small cell lung cancer in the US and outcomes with radiation or chemotherapy monotherapies
- 13 Jan 20
- Lung Cancer
-
Full paper
Tumor autoantibodies (TAAs) panel can improve the accuracy of early diagnosis in lung cancer presenting with ground-glass nodules (GGNs) in Chinese population
- 9 Feb 18
- Lung Cancer
-
Full paper
25 The impact of emergency presentations on lung cancer survival in a district general hospital – a review of new in-patient lung cancer referrals to the respiratory specialist nurse service at Conquest Hospital, East Sussex, UK
- 1 Jan 16
- Lung Cancer
-
Full paper
1 A comparative analysis of cancer hotspot mutation profiles in circulating tumour cells, circulating tumour DNA and matched primary lung tumour
- 1 Jan 16
- Lung Cancer
-
Full paper
20 Transformation of EML4/ALK positive adenocarcinoma of the lung to small cell lung cancer following ALK targeted therapy
- 1 Jan 16
- Lung Cancer
Scite analysis
Powered by scite_
24.4k articles received 179.3k citations see all
- 9,682 Supporting
- 163,983 Mentioning
- 1,814 Contrasting
Editorial notices
- 5 Retractions
- 6 Withdrawals
- 0 Corrections
- 70 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
57%
4 to 6 months
34%
7 to 9 months
8%
Above 9 months
1%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Lung Cancer been actively publishing?
Lung Cancer has been in operation since 1985 till date.
What is the publishing frequency of Lung Cancer ?
Lung Cancer published with a Monthly frequency.
How many articles did Lung Cancer publish last years ?
In 2023, Lung Cancer published articles.
What is the eISSN & pISSN for Lung Cancer ?
For Lung Cancer,eISSN is 1872-8332 and pISSN is0169-5002.
What is Citescore for Lung Cancer ?
Citescore for Lung Cancer is 9.4.
What is H index for Lung Cancer ?
H index for Lung Cancer is 141.
What is SNIP score for Lung Cancer ?
SNIP score for Lung Cancer is 1.44.
What is the SJR for Lung Cancer ?
SJR for Lung Cancer is Q1.
Who is the publisher of Lung Cancer ?
ELSEVIER IRELAND LTD is the publisher of Lung Cancer.